Skip to main content

Advertisement

Log in

Cripto-1 is overexpressed in carcinoma ex pleomorphic adenoma of salivary gland

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Introduction

Cripto-1 is a member of the epidermal growth factor—Cripto-1/FRL-1/Cryptic family. Besides being critical for early embryonic development, Cripto-1 is also associated with the development and behavior of several cancers. Objective: We analyzed the immunoexpression of Cripto-1 in normal salivary glands (NSGs), pleomorphic adenomas (PAs), and carcinoma ex pleomorphic adenomas (CaExPAs) of salivary glands.

Methods

A total of 12 NSGs, 16 PAs and 12 CaExPAs underwent immunohistochemical study by the polymeric biotin-free technique. Immunopositive cells were evaluated semiquantitatively (scores 0–3). For statistical analysis, Mann–Whitney and Kruskal–Wallis tests were performed and a significance level of p ≤ 0.05 was established.

Results

Most CaExPAs (n = 10) were strong positive (score 3) for Cripto-1, and only three cases of PAs and two specimens of NSGs exhibited some expression (score 1), being statistically significant these findings (p < 0.001). No difference between the expression of this protein in tumors of major and minor salivary glands was observed. Overexpression was found mainly in cases of CaExPAs with invasive growth (n = 8) when compared to those without capsular invasion (intracapsular pattern) (p = 0.036). Patients with or without lymph node metastasis showed no difference (p = 0.294).

Conclusion

The results revealed a significantly higher expression of Cripto-1 in CaExPA compared to PA and NSG, suggesting this protein is possibly deregulated in PA malignant transformation. Furthermore, the increased expression of this protein is associated with a more aggressive behavior (invasive growth) in salivary gland tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mariano FV, Noronha ALF, Gondak RO, Altemani AM, De Almeida OP, Kowalski LP (2013) Carcinoma ex pleomorphic adenoma in a Brazilian population: clinico-pathological analysis of 38 cases. Int J Oral Maxillofac Surg 42:685–692. https://doi.org/10.1016/j.ijom.2013.02.012

    Article  PubMed  CAS  Google Scholar 

  2. Alaizari NA, Tarakji B, Al-Maweri SA, Al-Shamiri HM, Darwish S, Baba F (2015) p53 expression in pleomorphic adenoma of salivary glands: a systematic review and meta-analysis. Arch Oral Biol 60:1437–1441. https://doi.org/10.1016/j.archoralbio.2015.06.019

    Article  PubMed  CAS  Google Scholar 

  3. Silva LP, Santana T, Sedassari BT, de Sousa SM, Sobral APV, Freitas RA et al (2017) Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma. Eur Arch Otorhinolaryngol 274:3203–3209. https://doi.org/10.1007/s00405-017-4605-9

    Article  PubMed  Google Scholar 

  4. Di Palma S (2013) Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. Head Neck Pathol 7:68–76. https://doi.org/10.1007/s12105-013-0454-z

    Article  PubMed Central  Google Scholar 

  5. Liu Q, Cui X, Yu X, Bian BS, Qian F, Hu XG et al (2017) Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Mol Cancer 16:81. https://doi.org/10.1186/s12943-017-0650-7

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Mahmoudian RA, Abbaszadegan MR, Forghanifard MM, Moghbeli M, Moghbeli F, Chamani J et al (2017) Biological and clinicopathological significance of Cripto-1 expression in the progression of human ESCC. Rep Biochem Mol Biol 5:83–90

    PubMed  PubMed Central  CAS  Google Scholar 

  7. Skalova A, Hellquist H (2014) Histopathology of the salivary glands. Springer, Berlin

    Google Scholar 

  8. El-Naggar A, Chan JKC, Grandis JR, Takata T, Slootweg PJ (2017) WHO classification of head and neck tumours. IARC Press, Lyon

    Google Scholar 

  9. Yoon HJ, Hong JS, Shin WJ, Lee YJ, Hong KO, Lee JI et al (2011) The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma. Oral Oncol 47:1023–1031. https://doi.org/10.1016/j.oraloncology.2011.07.019

    Article  PubMed  CAS  Google Scholar 

  10. Gao M, Hao Y, Huang MX, Ma DQ, Chen Y, Luo HY et al (2017) Salivary gland tumours in a northern Chinese population: a 50-year retrospective study of 7190 cases. Int J Oral Maxillofac Surg 46:343–349. https://doi.org/10.1016/j.ijom.2016.09.021

    Article  PubMed  CAS  Google Scholar 

  11. Wu Z, Li G, Wu L, Weng D, Li X, Yao K (2009) Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. BMC Cancer 9:315. https://doi.org/10.1186/1471-2407-9-315

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Xu CH, Cao L, Wei Y, Yu LK (2015) Serum cripto-1 as a clinical marker for lung cancer. Int J Biol Markers. 30:e369-373. https://doi.org/10.5301/jbm.5000155

    Article  CAS  Google Scholar 

  13. Zhang H, Zhang B, Gao L, Zhang L, Zhu K, Cheng R et al (2017) Clinical significance of cripto-1 expression in lung adenocarcinoma. Oncotarget 8:79087–79098. https://doi.org/10.18632/oncotarget.15761

    Article  PubMed  PubMed Central  Google Scholar 

  14. Francescangeli F, Contavalli P, De Angelis ML, Baiocchi M, Gambara G, Pagliuca A et al (2015) Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer. Cell Death Differ 22:1700–1713. https://doi.org/10.1038/cdd.2015.19

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Wei B, Jin W, Ruan J, Xu Z, Zhou Y, Liang J et al (2015) Cripto-1 expression and its prognostic value in human bladder cancer patients. Tumour Biol 36:1105–1113. https://doi.org/10.1007/s13277-014-2695-1

    Article  PubMed  CAS  Google Scholar 

  16. Wang JH, Wei W, Xu J, Guo ZX, Xiao CZ, Zhang YF et al (2015) Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma. Oncotarget 6:35116–35128. https://doi.org/10.18632/oncotarget.5057

    Article  PubMed  PubMed Central  Google Scholar 

  17. Castro NP, Fedorova-Abrams ND, Merchant AS, Rangel MC, Nagaoka T, Karasawa H et al (2015) Cripto-1 as a novel therapeutic target for triple negative breast cancer. Oncotarget 6:11910–11929. https://doi.org/10.18632/oncotarget.4182

    Article  PubMed  Google Scholar 

  18. Ligtenberg MA, Witt K, Galvez-Cancino F, Sette A, Lundqvist A, Lladser A et al (2016) Cripto-1 vaccination elicits protective immunity against metastatic melanoma. Oncoimmunology 5:e1128613. https://doi.org/10.1080/2162402X.2015.1128613

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Sun G, Yan SS, Shi L, Wan ZQ, Jiang N, Fu LS et al (2016) MicroRNA-15b suppresses the growth and invasion of glioma cells through targeted inhibition of cripto-1 expression. Mol Med Rep 13:4897–4903. https://doi.org/10.3892/mmr.2016.5126

    Article  PubMed  CAS  Google Scholar 

  20. Huang C, Chen W, Wang X, Zhao J, Li Q, Fu Z (20150 Cripto-1 promotes the epithelial-mesenchymal transition in esophageal squamous cell carcinoma cells. Evid Based Complement Alternat Med. 2015:421285. https://doi.org/10.1155/2015/421285

  21. Liu Y, Qin Z, Yang K, Liu R, Xu Y (2017) Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling. Oncol Rep 37:1521–1528. https://doi.org/10.3892/or.2017.5378

    Article  PubMed  CAS  Google Scholar 

  22. Klauzinska M, McCurdy D, Rangel MC, Vaidyanath A, Castro NP, Shen MM et al (2015) Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway. Am J Pathol 185:2907–2922. https://doi.org/10.1016/j.ajpath.2015.07.023

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S et al (2010) Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101:93–299. https://doi.org/10.1111/j.1349-7006.2009.01419.x

    Article  CAS  Google Scholar 

  24. Rangel MC, Karasawa H, Castro NP, Nagaoka T, Salomon DS, Bianco C (2012) Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer. Am J Pathol 180:2188–2200. https://doi.org/10.1016/j.ajpath.2012.02.031

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Brazilian National Council for Scientific and Technological Development (CNPq) and Coordination for the Improvement of Higher Education Personnel (CAPES).

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leorik Pereira Silva.

Ethics declarations

Ethical approval

All procedures performed in this study involving the patient were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The approval of the local ethics committee is present in the methods section in this article.

Informed consent

Informed consent was obtained from the patients in this study.

Conflict of interest

All authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, L.P., da Silva, L.A.B., Sedassari, B.T. et al. Cripto-1 is overexpressed in carcinoma ex pleomorphic adenoma of salivary gland. Eur Arch Otorhinolaryngol 275, 1595–1600 (2018). https://doi.org/10.1007/s00405-018-4960-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-018-4960-1

Keywords

Navigation